In a groundbreaking achievement, the Global Robotic Biopsy Devices Industry has attained an unprecedented valuation of US$ 440.2 million in 2023, as reported by a recent study. The industry is poised for continued success, with projections indicating a robust Compound Annual Growth Rate (CAGR) of 9.3% throughout the forecast period. The remarkable growth of the …